Ticker
LRMR
Larimar Therapeutics, Inc.
Quiet Money · how it holds up when sold
No Quiet Money read for LRMR yet. Pro adds any actively traded US stock overnight. See Pro →
The other money · last 90 days
Short sellers are backing off and insiders are buying.
- Short sellers−23% · 10.5M shares shortBacking off
- US Housenone filedNo trades
- Insiders$402,143 · 9 insidersBuying
LRMR in the last 90 days
Larimar Therapeutics, Inc. (LRMR) short interest: FINRA’s latest report (settlement 30 OCT 2026) shows 10,538,346 shares held short, 8.3 days to cover, down 28.1% from the report before.
LRMR also had no US House transactions and 9 insider purchases worth $402,143 by 9 insiders in filings from the last 90 days.
- Insiders: open-market purchases only (Form 4 code P); a purchase filed by related owners counts once.
- Delay: each filing below shows how many days passed between the trade and its publication. None of this is real-time.
Latest filing on file: 18 NOV 2026 · FINRA settlement 30 OCT 2026 · public filings, reported as filed ·
What the filings show
How the other money is read
Filings read · last 90 days
2 of 4 inputs have filings
Leaning in
The disclosed money is leaning into this name, on what has actually been filed. This reads on two of its four inputs.
Not in this read: US House trades (none filed in 90 days); EU short registers (they cover European-listed companies). A missing input is left out, not counted as balanced.
- Short interest
- Short interest fell 23.2% — 13,721,861 to 10,538,346 shares between 31 AUG 2026 and 30 OCT 2026. See the filings →
- Leans in
- Insider purchases
- 9 insiders disclosed buying $402,143 across 9 filings.
- Leans in
This summarises filings that have already been published — it is not a forecast, a rating of the company, or advice. Every figure above is listed in full further down this page, with the document it came from.
FINRA short interest
Settlement 30 OCT 2026 · shares held short
10,538,346shares held short
Days to cover
8.25
Avg daily volume
1,277,756
Since last report
-28.13%
What this number means ↓
As of 30 October 2026, 10,538,346 Larimar Therapeutics, Inc. shares were held short — the total across every reporting firm, not one fund's position. That is 4,124,563 shares fewer than the previous report, a 28.13% decrease. At the average daily volume of 1,277,756 shares, that position represents 8.25 days of trading — what the filing calls days to cover.
This is the most recent figure that exists, and it is 24 days old. FINRA collects short interest twice a month, on a settlement date, and publishes it seven business days later. So nobody has a live short-interest number for LRMR — not us, and not anyone quoting one. We print the settlement date on the figure so you always know which day you are looking at.
Across the 12 reports we hold, the position has risen from 8,744,601 shares on 15 May 2026 to 10,538,346 today, a change of 20.5%. The highest reading in that window was 15,369,771 shares on 30 September 2026.
| Settlement | Shares short | Days to cover |
|---|---|---|
| 30 OCT 2026 | 10,538,346 | 8.25 |
| 15 OCT 2026 | 14,662,909 | 8.95 |
| 30 SEPT 2026 | 15,369,771 | 8.70 |
| 15 SEPT 2026 | 13,894,306 | 14.89 |
| 31 AUG 2026 | 13,721,861 | 15.33 |
| 14 AUG 2026 | 13,443,456 | 11.23 |
| 31 JUL 2026 | 12,190,367 | 9.38 |
| 15 JUL 2026 | 11,303,953 | 4.89 |
| 30 JUN 2026 | 12,193,251 | 3.18 |
| 15 JUN 2026 | 10,535,603 | 5.06 |
| 29 MAY 2026 | 8,046,494 | 5.28 |
| 15 MAY 2026 | 8,744,601 | 4.32 |
Questions about short interest ↓
- What is LRMR's short interest?
- 10,538,346 shares, as of the 30 October 2026 settlement date. That is the figure FINRA published, unadjusted.
- What percentage of the float is short?
- We do not publish that, because FINRA does not publish float. The regulator reports the number of shares held short; turning it into a percentage needs a share count from somewhere else, and different sources disagree about what counts as float. We would rather give you the number that was actually filed than a percentage built on an assumption.
- How current is this?
- It is 24 days old, and that is as fresh as short interest gets. FINRA measures it twice a month and publishes it seven business days after the settlement date. Any site showing you a "live" short interest figure is showing you something else.
- What does days to cover mean?
- It is the short position divided by average daily trading volume — here, 8.25. It describes how many days of ordinary trading the position is equivalent to. It is arithmetic from the filing, not a prediction about what will happen.
- Where does this come from?
- FINRA's consolidated short interest file, which is public. We read it directly and store it unchanged, except that we blank the days-to-cover placeholder FINRA writes when a stock has almost no volume.
Disclosed insider buying on file
$402,143across 9 purchases
Open-market purchases only — the amount is a fact, not a verdict.
On file here
Named EU short positionsnot covered
Insider purchases9
US House transactions0
The EU registers name short sellers in European-listed companies only. FINRA’s total for this stock is above.
Latest change18 NOV 2026
Insider purchases on file
SEC — Form 4 insider purchase
Clayton RussellChief Medical Officer
BOUGHTCommon Stock
$9,999
3,322 sh @ $3.01
16 NOV 2026 → filed 18 NOV 2026
Filed 2 days after the tradeSEC EDGAR · 0001193125-26-467167 →SEC — Form 4 insider purchase
SHERMAN JEFFREY WDirector
BOUGHTCommon Stock
$10,058
3,289.474 sh @ $3.058
16 NOV 2026 → filed 16 NOV 2026
Filed the same day as the tradeSEC EDGAR · 0001193125-26-463941 →SEC — Form 4 insider purchase
Hamilton Thomas EdwardDirector
BOUGHTCommon Stock
$187,082
70,000 sh @ $2.673
12 NOV 2026 → filed 12 NOV 2026
Filed the same day as the tradeSEC EDGAR · 0001193125-26-459008 →SEC — Form 4 insider purchase
Harlow John B. Jr.President and COO
BOUGHTCommon Stock
$49,918
17,800 sh @ $2.804
11 NOV 2026 → filed 12 NOV 2026
Filed 1 day after the tradeSEC EDGAR · 0001193125-26-458845 →SEC — Form 4 insider purchase
Celano MichaelChief Financial Officer
BOUGHTCommon Stock
$49,992
18,460 sh @ $2.708
11 NOV 2026 → filed 12 NOV 2026
Filed 1 day after the tradeSEC EDGAR · 0001193125-26-458834 →SEC — Form 4 insider purchase
Shankar GopiChief Development Officer
BOUGHTCommon Stock
$13,549
5,000 sh @ $2.71
11 NOV 2026 → filed 12 NOV 2026
Filed 1 day after the tradeSEC EDGAR · 0001193125-26-458830 →SEC — Form 4 insider purchase
Truitt JosephDirector
BOUGHTCommon Stock
$9,792
3,500 sh @ $2.798
11 NOV 2026 → filed 12 NOV 2026
Filed 1 day after the tradeSEC EDGAR · 0001193125-26-458847 →SEC — Form 4 insider purchase
THOMAS FRANK EDirector
BOUGHTCommon Stock
$21,800
8,000 sh @ $2.725
11 NOV 2026 → filed 12 NOV 2026
Filed 1 day after the tradeSEC EDGAR · 0001193125-26-458848 →SEC — Form 4 insider purchase
BEN-MAIMON CAROLEDirector / President and CEO
BOUGHTCommon Stock
$49,953
18,050 sh @ $2.768
11 NOV 2026 → filed 12 NOV 2026
Filed 1 day after the tradeSEC EDGAR · 0001193125-26-458853 →